(Q42982795)

English

Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.

scientific article published on January 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Yoshihiko Maehara

10

object named as

Yoshihiko Maehara

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Kensaku Sanefuji

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hiroto Kayashima

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tomohiro Iguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Keishi Sugimachi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yo-Ichi Yamashita

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tomoharu Yoshizumi

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yuji Soejima

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Takashi Nishizaki

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akinobu Taketomi

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

32-37

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21176

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21176

21 January 2018

Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21176

21 January 2018

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21176

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21176

21 January 2018

Identifiers

10.1002/JSO.21176

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42982795&oldid=1590805435"